We invest in technology visionaries solving complex problems to reshape our world. Through a unique mix of expertise and resources, we build long-term partnerships with bold teams to accelerate their journeys.
NVentures' insightful diligence and alignment with our vision have been instrumental. Together, Moon Surgical and NVIDIA are unlocking the immense potential of the most powerful edge computer in the OR.
— Anne Osdoit (CEO), Moon Surgical
NVentures has a network, not just within NVIDIA, but throughout the industry… [This ensures that] we have access to the best technology and the best people to build all the different modules that have to come together to define the distribution and supply chain of the future.
— Andrew Smith (CEO), Outrider
Our collaboration with NVIDIA is enabling us to deliver the fastest computing solutions to our customers so they can iterate quickly through design options and deliver products to market faster than ever.
— Bradley Rothenberg (CEO), nTop
NVentures’ team consists of experienced professionals with both significant operating and investing experience, thus providing a critical eye in the boardroom. The NVIDIA team helped CHARM set up our on-prem NVIDIA cluster consisting of 128 A100s to start with, which has been transformative in helping us train next-generation protein-ligand folding models.
— Laksh Aithani (CEO), Charm Therapeutics
moon-surgical
outrider
nTop
charm-therapeutics
Investing in What Comes Next
Learn more about joining the NVIDIA portfolio of visionary companies.
Pioneering biological software, a new class of medicine and biotechnologies in which molecules are programmed to perform specific functions native to biological systems
Enterprise-grade technology that transforms patient-clinician conversations into structured clinical notes in real time with deep electronic medical record integrations
The first drug-generation company to pioneer a machine learning-powered generative biology platform that can create new drugs on demand across a wide range of biologic modalities
A biotechnology company integrating experimentation at scale and generative AI to improve the speed, cost, and success rate of small-molecule drug discovery and development